Defining SARS-CoV-2 immune maintenance in the Australian population

  • Smith, Corey (Primary Chief Investigator (PCI))
  • Gras, Stephanie (Chief Investigator (CI))
  • Short, Kirsty R (Chief Investigator (CI))
  • Jacobson, Kim (Chief Investigator (CI))
  • Hartel, Gunter F (Chief Investigator (CI))
  • Barrett, Helen (Chief Investigator (CI))
  • Kitchener, Scott (Chief Investigator (CI))

Project: Research

Project Details

Project Description

Control of viruses in humans is dependent on B cells that produce antibodies to recognise and neutralise virus particles, and T cells that recognise and remove virally infected cells. Currently, we do not know how long immune cells live for in individuals who have recovered from COVID-19. This must be determined in order to assess the risk of reinfection and identify which part of the population may benefit from vaccine boosters if a COVID-19 vaccine becomes available.
Effective start/end date1/11/201/11/22


  • Department of Health and Aged Care (Australia): A$998,876.00